CD2 and cancer: From each patient, the transcriptome of the CD2+ lymphocytic cells is also sequenced, both as a source of signals of the body’s lymphocytic response to the presence of a developing tumor, but also as a patient-specific white blood cell control for the phagocytic macrophages that potentially possess cancer-specific signals when cleaning up apoptotic tumor cells.